Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| RNA polymerase | R-HSA-73864 | map03020 | chloropyrazine | 33478 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | monocrotaline | 9415 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | monocrotaline | 9415 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | monocrotaline | 9415 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | harmine | 6178111 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | harmine | 6178111 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | harmine | 6178111 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | harmine | 6178111 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | harmine | 6178111 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | harmine | 6178111 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | harmine | 6178111 | drug-path |
| PPAR signaling pathway | R-HSA-168638 | map03320 | harmine | 6178111 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | harmine | 6178111 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | harmine | 6178111 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | harmine | 6178111 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | harmine | 6178111 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | harmine | 6178111 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | harmine | 6178111 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | harmine | 6178111 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | harmine | 6178111 | drug-path |